Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
3,430,885
-
Shares change
-
+2,024,976
-
Total reported value, excl. options
-
$86,264,057
-
Value change
-
+$50,636,627
-
Put/Call ratio
-
2.06%
-
Number of buys
-
21
-
Number of sells
-
-13
-
Price
-
$25.16
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q3 2020
43 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q3 2020.
AVITA Medical, Inc. - Common Stock (RCEL) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,430,885 shares
of 26,475,256 outstanding shares and own 12.96% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (1,779,586 shares), Blackcrane Capital, LLC (474,982 shares), VANGUARD GROUP INC (284,911 shares), GEODE CAPITAL MANAGEMENT, LLC (176,321 shares), KAMES CAPITAL plc (133,975 shares), BlackRock Inc. (131,666 shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (102,236 shares), RENAISSANCE TECHNOLOGIES LLC (76,172 shares), Allianz Asset Management GmbH (54,924 shares), and MCF Advisors LLC (36,812 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.